URGN
UroGen Pharma Ltd. Ordinary Shares
$19.23
-0.47%
-0.09
Notify me if price changes either direction
Buy URGN stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
900.1M
Enterprise value
907.7M
Trailing PE
-6.4966214669717
Forward PE
-17.572727
PEG Ratio
-0.25522441477389
Enterprise to EBITDA
-6.924
Enterprise to revenue
9.405
Price to book MRQ
-8.0076208822705
Price to sales TTM
9.374776
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
96.5M
EBITDA
-131105000
Diluted EPS TTM
-3.47
Total Cash (MRQ)
127.0M
Current ratio (MRQ)
3.99
Operating Cash Flow (TTM)
-137738000
URGN trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
January 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
